Rajputana Biodiesel receives Rs 11.83 crore LOI from Bpcl ahead of formal contract
Rajputana Biodiesel receives Rs 11.83 crore LOI from Bpcl, adding to Rs 8.37 crore from Iocl in Q2FY27. Total disclosed order book is Rs 20.20 crore. Execution risk remains high as LOIs are not firm contracts. Balance sheet is healthy (Current Ratio 2.04x), but operating cashflows are negative.

*this image is generated using AI for illustrative purposes only.
WHAT HAPPENED
Rajputana Biodiesel received a Letter of Intent (LOI) valued at Rs 11.83 crore from Bharat Petroleum Corporation Limited (Bpcl). The scope covers execution during the period June 2026 to August 2026. This filing classifies the order as "Significant" but explicitly notes the terms are "As per the Letter of Intent," indicating that the full contract is not yet formalised. Revenue recognition for this value will begin only after the issuance of a formal work order or Letter of Award (LOA).
ORDER IN FINANCIAL CONTEXT
The Rs 11.83 crore LOI represents advance engineering or mobilisation costs rather than a firm contract value. When combined with the previous LOI of Rs 8.37 crore from Indian Oil Corporation Limited (Iocl), the total disclosed order book stands at Rs 20.20 crore (sum of the 2 orders disclosed across the last 3 fiscal quarters shown in the table below). Given the Trailing Twelve Month (TTM) revenue is currently reported as Rs 0.0 crore, the book-to-bill ratio cannot be computed on a trailing basis. However, relative to the average quarterly revenue derived from FY26 annual data (Rs 30.51 crore per quarter), the current backlog represents approximately 0.66 quarters of coverage. The critical metric here is the conversion rate: how quickly these LOIs translate into binding work orders that allow revenue booking.
COMPANY ORDER TRACK RECORD
Order inflow velocity appears stable, with two distinct LOIs secured in the current quarter from major public sector oil marketing companies. The consistency in per-order size (Rs 8.37 crore and Rs 11.83 crore) suggests the company is targeting mid-sized supply contracts within its operational capacity.
| Quarter: | Total Order Inflow (Rs Cr): | Key Awarding Entities: |
|---|---|---|
| Q2FY27 (Jul-Sep 2026) | 8.37 (1 orders) | Indian Oil Corporation Limited (IOCL) |
Note: The Rs 20.20 crore total includes the Rs 8.37 crore Iocl LOI dated July 21, 2026, and the Rs 11.83 crore Bpcl LOI dated July 27, 2026.
EXECUTION AND REVENUE QUALITY
The latest consolidated financials show zero revenue and profit for the trailing twelve months, likely reflecting the fiscal year transition period where full-year data has not yet been aggregated into the TTM window. Historical annual data provides better context for execution quality.
| Quarter: | Revenue (Rs Cr): | Net Profit (Rs Cr): | OPM (%): |
|---|---|---|---|
| TTM | 0.0 | 0.0 | 0.0% |
REVENUE GROWTH - ORDER WINS TRANSLATING TO REVENUE
As Rajputana Biodiesel has sustained order wins, with consistent LOIs from major oil marketing companies in Q2FY27, its annual revenue has grown from Rs 68.60 crore in FY25 to Rs 122.03 crore in FY26, representing a YoY growth of +77.9% based on the latest annual data. This historical growth trajectory supports the view that the company has the capacity to execute larger volumes, provided LOIs convert to firm contracts.
WORKING CAPITAL AND EXECUTION CAPACITY
The company’s balance sheet offers adequate liquidity to fund initial mobilisation. The current ratio stands at 2.04x, indicating sufficient current assets to cover short-term liabilities. Total Liabilities/Equity is 0.83x, which is well below the 2.0x threshold for elevated leverage concerns. However, operating cashflow was negative at -Rs 15.30 crore in FY25, suggesting that working capital cycles may be stretched or that cash outflows for inventory and capex are outpacing collections. Monitoring whether the new orders improve cash conversion efficiency is important.
WHAT TO WATCH
- Formal Work Order Issuance: The Rs 11.83 crore LOI must be converted into a formal Letter of Award (LOA) or Work Order before any revenue can be recognized. Delays in this process pose execution risk.
- Execution Rate: Monitor quarterly revenue run-rates against the total backlog. With TTM revenue at zero, the next few quarters will be critical in establishing the new revenue baseline.
- Cash Conversion: Operating cashflow has been negative for four consecutive years (FY22-FY25). Watch for improvement in free cashflow as new orders begin execution.
- Client Concentration: Both recent LOIs are from public sector undertakings (Bpcl and Iocl). While this reduces counterparty credit risk, it increases dependency on government procurement cycles.
KEY OBSERVATIONS
- Contract structure: This is a mobilisation / LNTP order. Revenue recognition begins only after formal work order issuance. The Rs 11.83 crore represents advance engineering costs, not the full contract value.
- Cash conversion: Operating cashflow of -Rs 15.30 crore in FY25; backlog is not converting to cash efficiently, and receivables or working capital cycle may be stretched.
- Valuation check (as of 29 Jul 2026): P/E of 13.1x against ROCE of 19.44%. At the time of this article, valuation was pricing in execution improvement not yet visible in return ratios. (P/E is price-derived and will change; ROCE is from audited financials)
Historical Stock Returns for Rajputana Biodiesel
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.61% | -2.73% | -4.22% | -14.71% | -13.16% | -25.20% |




























